A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales (2018-2021)
Experts
Dr
Adam Stewart
ATH - Senior Lecturer
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
